Commercial Oncology Pipeline Director

Start free →

Or apply yourself on the official page →

About the role

Uniting science, technology and talent to get ahead of disease together GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. ​ We prevent and treat disease with specialty medicines, vaccines and general medicines. We focus on the science of the immune system and advanced technologies, investing in four core therapeutic areas – respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale. ​ ​ People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can perform and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people. GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our positive impact on people’s health. ​ Our strategy is to prevent and treat disease with specialty medicines, vaccines and general medicines. ​ ​ We combine the science of the immune system with advanced technologies, enhanced by targeted business development and world-class partnerships, to develop new medicines and vaccines that can help transform people’s lives. Position Summary The Oncology Pipeline Director is responsible for representing the Canadian commercial perspective across the lifecycle of key novel oncology assets or indications including ensuring development, commercialization strategy, and launch planning are optimized for the Canadian market. This role serves as the primary Canadian commercial leader interfacing with the global asset team and regional asset teams for all Oncology assets or indications, providing strategic guidance and input on Canadian needs for commercial readiness to maximize asset / indication value. The Director will work cross-functionally with Medical Affairs, Market Access, Regulatory and Business Intelligence in Canada to shape the development path and commercialization strategy for the assets / indications including prioritization, resource and investment allocation / timing and business case / P&L development. The role requires deep expertise in Canadian oncology market dynamics, competitive intelligence, payer landscape, and launch excellence, ensuring the Canadian perspective is considered and localized from global or regional strategy. Responsibilities This role will provide YOU the opportunity to lead key activities to progress YOUR career. These responsibilities include some of the following: Canada Oncology Asset / Indication Strategy Leadership: • Serve as the Canadian commercial lead for all oncology assets / indications on global and regional teams, ensuring the Canadian perspective is considered in development and commercialization decisions. • Shape Canadian positioning strategy, value proposition, and differentiation relative to current and emerging competitors. • Member of the Oncology Leadership Team • Translate Canadian market insights into actionable strategy for local and global/regional teams as needed. • Partner with local Medical and Clinical teams to ensure understanding of local drivers and barriers of success of clinical trial sites in Canada and implications for potential commercial success or needs. • Identify opportunities to optimize label potential and market access positioning. Canada Market Intelligence & Competitive St

View the official posting →